| FAIFX | TRSGX | FAIFX / TRSGX | |
| Total Expense Ratio | 0.34 | 0.78 | 44% |
| Annual Report Gross Expense Ratio | 0.34 | 0.92 | 37% |
| Fund Existence | 5 years | 31 years | - |
| Gain YTD | 9.766 | 10.445 | 93% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 140B | 3.83B | 3,659% |
| Annual Yield % from dividends | 3.70 | 1.33 | 279% |
| Returns for 1 year | 8.92 | 8.96 | 100% |
| Returns for 3 years | 28.21 | 39.96 | 71% |
| Returns for 5 years | 32.93 | 12.09 | 272% |
| Returns for 10 years | N/A | 68.20 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RZC | 25.84 | 0.04 | +0.16% |
| Reinsurance Group of America | |||
| CSHI | 49.68 | -0.01 | -0.02% |
| NEOS Enhanced Inc 1-3 Month T-Bill ETF | |||
| MBB | 95.36 | -0.06 | -0.06% |
| iShares MBS ETF | |||
| PGHY | 19.93 | -0.02 | -0.10% |
| Invesco Glb ex-US High Yld Corp Bd ETF | |||
| BBC | 39.56 | -0.76 | -1.88% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||